genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
News
Bioprocessing
Gates Biomanufacturing Reaches Milestone
Bioprocessing
EV Biologics Approves Plan to Scale Up Exosome Drug Manufacture
Regenerative Medicine/Tissue Engineering
Researchers Pinpoint the Workings behind Liver Regeneration
OMICs
New Bone Cell Type Identified, Could Point to Drug Targets for…
OMICs
Large-Scale Biobank Study Links Primary Cilium to Diabetes, Kidney Disease, and…
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
Gates Biomanufacturing Reaches Milestone
Bioprocessing
EV Biologics Approves Plan to Scale Up Exosome Drug Manufacture
Regenerative Medicine/Tissue Engineering
Researchers Pinpoint the Workings behind Liver Regeneration
OMICs
New Bone Cell Type Identified, Could Point to Drug Targets for…
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Antibodies
Bispecific Antibodies
Bispecific Antibodies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bispecific Antibodies
Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer
Bispecific Antibodies
AbCellera’s CEO: Flattening the Curve of Technology Development
Bispecific Antibodies
Genmab Partners on Cancer Antibodies with BliNK Biomedical, Launches $503M U.S. IPO
Bispecific Antibodies
Recent Advances and the Future of Antibody Engineering
Bispecific Antibodies
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Bispecific Antibodies
Sanofi to Develop Biomunex Bi-, Multi-Specific Antibodies for Immuno-Oncology and Other...
Bispecific Antibodies
Bispecific Playgrounds? No, Factory Floors
Bispecific Antibodies
Bispecific Antibodies Grapple with Cancer by Grabbing T Cells
Bispecific Antibodies
Daiichi Sankyo Triples Down on Immuno-Oncology Collaboration with Zymeworks
Bispecific Antibodies
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Bispecific Antibodies
Bifunctional Antifungal Besets the Cell Wall, Rallies Antibodies to the Siege
Bispecific Antibodies
Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates...
Bispecific Antibodies
Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy Targeting 4-1BB
Bispecific Antibodies
F-star, Merck Agree Up to €1B Deal to Develop Five Bispecific...
Bispecific Antibodies
EpimAb Raises $25M in Series A to Progress Bispecific Antibodies into...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![The structure of the ROR1-binding arm of the bispecific antibody in complex with ROR1 was determined by X-ray crystallography. [Rader lab/The Scripps Research Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/May31_2018_RaderLadScrippsInst_AntibodyBindingSite4715364246-324x160.jpg "Bispecific Antibodies Grapple with Cancer by Grabbing T Cells")
